ESTRO37_ProgrammeBook

> Pelvic re-irradiation with Stereotactic Ablative Radiotherapy (SABR): outcomes and cumulative doses L. Murray (United Kingdom), R. Speight, P. Dickinson, K. Franks, J. Lilley, A.L. Appelt, A. Henry > Stereotactic body radiation therapy for painful spinal metastases - results of a phase 2 study M. Guckenberger (Switzerland), R. Sweeney, M. Hawkins, J. Belderbos, N. Andratschke, M. Ahmed, I. Madani, F. Mantel, S. Steigerwald, M. Flentje > Equivalent cancer-specific survival following surgical resection or SABR for stage I lung cancer K. Spencer (United Kingdom), M. Kennedy, K. Lummis, D. Ellames, M. Snee, A. Brunelli, K. Franks, M. Callister SYMPOSIUM Enhancing radiation oncology outcomes through patient involvement 10:30 - 11:45  |  ROOM 116 This session explores how outcomes in practice can be optimised through the incorporation of patients in treatment decisions. Patient and radiation oncology professionals’ alliances can innovate and inspire technological advances in practice and determination of patient values and preferences is instrumental in this partnership. Analysis of longitudinal data from patient reported outcome measures (PROMS) can inform and benefit our practice. During this session, the analysis of PROMS data in relation to improving our understanding of the impact of both baseline and acute side-effects on late function and quality of life will be discussed. Chair: M. Leech (Ireland) Co-Chair: D. Franceschini (Italy) 10:51 > The impact of patient values on treatment techniques and decisions in radiation oncology Speaker: C. Marijnen (The Netherlands) 11:12 > Listening to patients: PROs analysis to improve communication and enhance practice Speaker: A. Lemanska (United Kingdom), D. Dearnaley, R. Jena, M. Sydes, S. Faithfull 10:30 > Patients as partners - advocacy, innovation and clinical trials Speaker: S. Turner (Australia)

MONDAY 23 APRIL 2018

PV-0474

PV-0475

PV-0476

SP-0477

SP-0478

SP-0479

SCIENTIFIC PROGRAMME | Programme and Exhibition Guide

148